万泽股份：11月20日召开董事会会议

Group 1 - The core point of the article is that Wanze Co., Ltd. announced the convening of its 11th Board of Directors meeting on November 20, 2025, to discuss the proposal for the fifth extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, Wanze Co., Ltd.'s revenue composition is as follows: pharmaceutical manufacturing accounts for 72.08%, manufacturing accounts for 26.65%, and other businesses account for 1.27% [1] - As of the time of reporting, Wanze Co., Ltd. has a market capitalization of 10.3 billion yuan [1]